• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IRX

INHALERX LIMITED

0.00% ! 2.5¢
Market Cap $5.336M  !

InhaleRx Limited is an Australia-based healthcare company. The Company is focused on... InhaleRx Limited is an Australia-based healthcare company. The Company is focused on developing medicinal drug-device products to address unmet medical needs in the pain management and mental health sectors. It is engaged in the development of precision medicine delivered through inhalation. The Company is focused on the development of innovative inhaled therapeutics. The Company’s novel drug device combinations target the treatment of breakthrough cancer pain (BTcP) (IRX211) and panic disorder (PD)(IRX611a), with the objective of helping to improve the quality of life of BTcP and PD sufferers. IRX211 is a THC based synthetic cannabinoid derived drug (dronabinol) delivered via a pMDI in a fixed dose designed to provide rapid onset analgesia for patients suffering with acute episodic bursts of breakthrough pain. It holds an approved innovation patent and has lodged an Australian provisional patent application for the treatment of BTcP with the Australian Patent Office.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IRX 18/04/25 3 790
18/04/25 Last post  mikevtss Comments Created with Sketch.  3  Views Created with Sketch.  790 
IRX
InhaleRX sets up Phase 1 trial for panic disorder inhaler
17/04/25 0 148
17/04/25 Last post  ASX Insights Comments Created with Sketch.  0  Views Created with Sketch.  148 
IRX
80 CENTS PRICE TARGET
01/04/25 40 20K
Metals & Mining SECTOR NEWS

More Strong Drilling Results for Apollo Hill Gold Project

STN
23 Apr 2025
SATURN METALS LIMITED
01/04/25 Last post  RiskRewardPro Comments Created with Sketch.  40  Views Created with Sketch.  20K 
IRX 28/03/25 0 167
28/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  167 
IRX 28/03/25 0 183
28/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  183 
IRX 28/03/25 0 237
28/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  237 
IRX 14/03/25 0 313
14/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  313 
IRX 13/03/25 2 752
13/03/25 Last post  mikevtss Comments Created with Sketch.  2  Views Created with Sketch.  752 

See All Discussions arrow Created with Sketch.

Timeline

IRX-616a Study Order Executed to Commence Phase 1
17 Apr 09:47
 
2024 Corporate Governance Statement
28 Mar 16:59
 
2024 Appendix 4G
28 Mar 16:58
 
2024 Annual Report
28 Mar 16:58
 
Shareholder Town Hall - Webinar Slides
14 Mar 15:32
 
Study Order Executed for Phase 2 BTcP Trial
13 Mar 14:50
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.5¢
Change
0.000(0.00%)
Mkt cap ! $5.336M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 270000 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 329412 3
View Market Depth
Last trade - 16.12pm 23/04/2025 (20 minute delay) ?
IRX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.